Lexicon Pharmaceuticals

Lexicon Pharmaceuticals is a biopharmaceutical company focused on discovering and developing drugs to treat human diseases. Its pipeline includes candidates for irritable bowel syndrome, type 2 diabetes, rheumatoid arthritis, carcinoid syndrome, and glaucoma. The company has collaborations with major pharmaceutical companies and other organizations.

Lonnel Coats

CEO and Board Member

Matthew Cullen

Vice President-Value and Access

Mike Exton

CEO

1 past transactions

Coelacanth

Acquisition in 2001
Coelacanth, which uses proprietary chemistry technologies to rapidly discover new chemical entities for drug development.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.